Apollon Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52M Buy
70,557
+20,438
+41% +$1.65M 0.07% 251
2026
Q1
$4.34M Buy
50,119
+2,586
+5% +$248K 0.07% 239
2025
Q4
$4.57M Buy
47,533
+1,293
+3% +$126K 0.08% 214
2025
Q3
$4.4M Buy
46,240
+1,648
+4% +$151K 0.08% 219
2025
Q2
$3.89M Buy
44,592
+265
+0.6% +$22.5K 0.08% 224
2025
Q1
$3.98M Buy
44,327
+2,114
+5% +$189K 0.09% 207
2024
Q4
$3.37M Buy
42,213
+383
+0.9% +$33.2K 0.08% 237
2024
Q3
$3.77M Sell
41,830
-5,193
-11% -$437K 0.11% 169
2024
Q2
$3.7M Sell
47,023
-2,638
-5% -$216K 0.11% 162
2024
Q1
$4.33M Sell
49,661
-1,143
-2% -$97.5K 0.14% 138
2023
Q4
$4.19M Buy
50,804
+15,265
+43% +$1.16M 0.14% 139
2023
Q3
$2.78M Buy
35,539
+1,189
+3% +$99.5K 0.14% 141
2023
Q2
$3.03M Buy
34,350
+13,092
+62% +$1.13M 0.15% 149
2023
Q1
$1.71M Buy
21,258
+876
+4% +$71.4K 0.11% 203
2022
Q4
$1.58M Sell
20,382
-3,704
-15% -$300K 0.11% 193
2022
Q3
$1.95M Sell
24,086
-489
-2% -$43.9K 0.16% 136
2022
Q2
$2.21M Buy
24,575
+2,271
+10% +$230K 0.18% 117
2022
Q1
$2.48M Sell
22,304
-7,550
-25% -$798K 0.18% 124
2021
Q4
$3.09M Buy
29,854
+18,156
+155% +$2.1M 0.23% 97
2021
Q3
$1.47M Buy
11,698
+8,834
+308% +$1.14M 0.2% 105
2021
Q2
$356K Sell
2,864
-288
-9% -$36.2K 0.06% 256
2021
Q1
$372K Buy
+3,152
New +$369K 0.07% 236
2020
Q3
Sell
-937
Closed -$86K 472
2020
Q2
$86K Buy
+937
New +$89.8K 0.05% 185

Other funds holding MDT

Apollon Wealth Management's MDT Position: Q2 2026 in Review

Apollon Wealth Management increased its Medtronic (MDT) stake by 41% in Q2 2026, buying an estimated $1.65M and bringing the position to 70,557 shares worth $5.52M. The position accounts for 0.07% of the portfolio, ranked #251.

Apollon Wealth Management first reported a position in MDT in Q2 2020 and has held it in 23 quarters since. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Apollon Wealth Management held 70,557 shares of Medtronic worth $5.52M as of Q2 2026.
  • Apollon Wealth Management bought 20,438 Medtronic shares in Q2 2026, an estimated $1.65M.
  • Medtronic made up 0.07% of Apollon Wealth Management's portfolio in Q2 2026, its #251 holding.
  • Apollon Wealth Management first reported a position in Medtronic in Q2 2020 and has held it in 23 quarters since.
  • 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.